Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms.
Strategies to induce biofilm dispersal are of interest due to their potential to prevent biofilm formation and biofilm-related infections. Nitric oxide (NO), an important messenger molecule in biological systems, was previously identified as a signal for dispersal in biofilms of the model organism Pseudomonas aeruginosa. In the present study, the use of NO as an anti-biofilm agent more broadly was assessed. Various NO donors, at concentrations estimated to generate NO levels in the picomolar and low nanomolar range, were tested on single-species biofilms of relevant microorganisms and on multi-species biofilms from water distribution and treatment systems. Nitric oxide-induced dispersal was observed in all biofilms assessed, and the average reduction of total biofilm surface was 63%. Moreover, biofilms exposed to low doses of NO were more susceptible to antimicrobial treatments than untreated biofilms. For example, the efficacy of conventional chlorine treatments at removing multi-species biofilms from water systems was increased by 20-fold in biofilms treated with NO compared with untreated biofilms. These data suggest that combined treatments with NO may allow for novel and improved strategies to control biofilms and have widespread applications in many environmental, industrial and clinical settings.
School of Biotechnology and Biomolecular Sciences and Centre for Marine Bio-Innovation, University of New South Wales, Sydney, NSW 2052, Australia.
Nicolas
N
Barraud
Michael V
MV
Storey
Zoe P
ZP
Moore
Jeremy S
JS
Webb
Scott A
SA
Rice
Staffan
S
Kjelleberg
D001419:Bacteria / Q000187:drug effects*; D018407:Bacterial Physiological Phenomena / Q000187:drug effects; D018441:Biofilms / Q000187:drug effects*; D006801:Humans; D009181:Mycoses / Q000382:microbiology*; D009569:Nitric Oxide / Q000494:pharmacology*; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D011552:Pseudomonas Infections / Q000382:microbiology*; D015003:Yeasts / Q000187:drug effects* / Q000502:physiology
D020030:Nitric Oxide Donors; D009569:Nitric Oxide
J Bacteriol. 1998 Feb;180(4):773-84
9473029
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8103-7
7690141
Photochem Photobiol. 1996 Aug;64(2):393-8
8760579
PLoS Comput Biol. 2005 Oct;1(5):e55
16261196
Infect Immun. 2003 May;71(5):2341-9
12704103
Arch Microbiol. 1993;160(4):253-64
8239880
Science. 2005 Jun 10;308(5728):1618-21
15919956
Infect Immun. 2007 Aug;75(8):3780-90
17526746
Chem Rev. 2002 Apr;102(4):1091-134
11942788
Biomaterials. 2005 May;26(14):1685-93
15576142
Plasmid. 1996 Jan;35(1):1-13
8693022
Free Radic Biol Med. 2004 Oct 1;37(7):926-36
15336308
Annu Rev Microbiol. 1995;49:711-45
8561477
J Ind Microbiol. 1995 Sep;15(3):141-7
8519469
Mol Microbiol. 2005 Aug;57(3):629-39
16045609
Emerg Infect Dis. 2002 Mar;8(3):336-8
11927038
Nat Biotechnol. 2003 Apr;21(4):361-5
12665817
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12558-63
16894146
Microbiology (Reading). 1996 Jul;142 ( Pt 7):1675-84
8757732
Am J Respir Crit Care Med. 2002 Apr 1;165(7):922-6
11934715
ACS Nano. 2008 Feb;2(2):235-46
19206623
Environ Sci Technol. 2005 Oct 1;39(19):7541-50
16245826
Science. 1980 Feb 8;207(4431):637-9
17749325
Nat Rev Microbiol. 2004 Feb;2(2):95-108
15040259
J Biol Chem. 2008 May 9;283(19):13140-7
18316370
Development. 1997 Sep;124(18):3587-95
9342051
Eur J Cell Biol. 1999 Mar;78(3):209-13
10219571
J Bacteriol. 1988 Dec;170(12):5855-62
3056919
J Biol Chem. 2002 May 3;277(18):16167-71
11856757
Crit Rev Microbiol. 2005;31(4):213-32
16417202
J Bacteriol. 2007 Nov;189(21):7911-9
17720780
Evol Dev. 2003 Sep-Oct;5(5):542-50
12950632
Biochemistry. 2000 Mar 14;39(10):2685-91
10704219
J Bacteriol. 2006 Dec;188(24):8327-34
17028282
Annu Rev Pharmacol Toxicol. 2003;43:585-607
12415121
J Bacteriol. 2006 Nov;188(21):7344-53
17050922
Microbiology (Reading). 2002 Jan;148(Pt 1):87-102
11782502
J Microbiol Methods. 2007 Aug;70(2):236-44
17524505